Literature DB >> 8370291

L-arginine pathway in the sepsis syndrome.

J A Lorente1, L Landín, R De Pablo, E Renes, D Liste.   

Abstract

OBJECTIVE: To investigate the role of nitric oxide in the regulation of vascular tone in patients with the sepsis syndrome.
DESIGN: Prospective, intervention study.
SETTING: Tertiary care hospital. PATIENTS: Fifteen patients admitted to our medical intensive care unit with the diagnosis of sepsis syndrome by defined criteria.
INTERVENTIONS: Eight patients received N omega-nitro-L-arginine (20 mg/kg, iv bolus) followed by L-arginine (200 mg/kg, iv bolus). Seven patients received L-arginine alone (200 mg/kg).
MEASUREMENTS AND MAIN RESULTS: In the first group, hemodynamic and oxygen transport variables were recorded at baseline, during 45 mins after the injection of N omega-nitro-L-arginine, and during 45 mins after the administration of L-arginine. In the second group, hemodynamic parameters were recorded at baseline and during 15 mins after the administration of L-arginine. Data are mean +/- SEM. The administration of N omega-nitro-L-arginine was followed by hypertension (mean blood pressure increased from 89 +/- 8 to a maximum of 140 +/- 12 mm Hg) accompanied by a decrease in cardiac index (from 3.51 +/- 0.39 to a minimum of 2.65 +/- 0.21 L/min/m2) and an increase in right atrial and pulmonary artery occlusion pressure. Systemic vascular resistance index increased from 1871.1 +/- 302.3 to 3825.6 +/- 244.4 dyne.sec/cm5.m2, and pulmonary vascular resistance increased from 533.2 +/- 125.8 to 816.0 +/- 117.3 dyne.sec/cm5.m2. These changes induced by N omega-nitro-L-arginine were reversed by the administration of L-arginine. The administration of L-arginine to another group of patients caused transient hypotension (from 103 +/- 6 to 81 +/- 10 mm Hg) and an increase in cardiac index (from 3.57 +/- 0.15 to 4.74 +/- 0.54 L/min/m2). Both systemic and pulmonary vascular resistance indices decreased (from 1987.6 +/- 163.9 to 1251.4 +/- 231.5 dyne.sec/cm5.m2, and from 486.1 +/- 65.2 to 380.5 +/- 70.3 dyne.sec/cm5.m2). Parallel to the increase in oxygen transport due to the increase in cardiac output, oxygen consumption index increased significantly 1 min after L-arginine (from 127.0 +/- 19.0 to 182.5 +/- 37.3 mL/min/m2). All mentioned changes were statistically significant (p < .05).
CONCLUSIONS: A continuous basal release of nitric oxide plays a role in the regulation of systemic and pulmonary vascular tone in patients with sepsis syndrome. L-arginine has systemic and pulmonary vasodilatory actions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370291     DOI: 10.1097/00003246-199309000-00010

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

1.  NO news is good news.

Authors:  M Sair; T W Evans
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

Review 2.  Is sepsis a mediator-inhibitor mismatch?

Authors:  M Lamy; G Deby-Dupont
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

Review 3.  The role of nitric oxide in sepsis and ARDS: synopsis of a roundtable conference held in Brussels on 18-20 March 1995.

Authors:  M P Fink; D Payen
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

Review 4.  Cardiac dysfunction in sepsis: new theories and clinical implications.

Authors:  R M Grocott-Mason; A M Shah
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

5.  Vasodilating prostaglandin E1 does not reproduce interleukin-1β-induced oxygen metabolism abnormalities in rabbits.

Authors:  Shigenari Matsuyama; Koichi Hayakawa; Kazuhito Sakuramoto; Takashi Muroya; Yasushi Nakamori; Hitoshi Ikegawa; Takeshi Shimazu; Yasuyuki Kuwagata
Journal:  Acute Med Surg       Date:  2014-10-22

Review 6.  Nitric oxide and septic shock. From bench to bedside.

Authors:  S J Kuhl; H Rosen
Journal:  West J Med       Date:  1998-03

7.  Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock.

Authors:  J A Avontuur; T C Stam; M Jongen-Lavrencic; J G van Amsterdam; A M Eggermont; H A Bruining
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

8.  Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

Review 9.  Nitric oxide: perspectives and emerging studies of a well known cytotoxin.

Authors:  William A Paradise; Benjamin J Vesper; Ajay Goel; Joshua D Waltonen; Kenneth W Altman; G Kenneth Haines; James A Radosevich
Journal:  Int J Mol Sci       Date:  2010-07-16       Impact factor: 5.923

10.  Effects of nitro-L-arginine on blood pressure and cardiac index in anesthetized rats: a pharmacokinetic-pharmacodynamic analysis.

Authors:  M A Tabrizi-Fard; H L Fung
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.